Fish Is Fish – Right? – Maybe the Story Should Read “A Fish by Any Other Name”!
While the Lachman Blog usually focuses on issues in drugs, devices, and biologics (the areas we consult in), we are swimmingly happy to take a walk (or dive) on the wild side to address a fishy problem that caught our attention. The FDA noted in a Federal Register Notice today (here) that contained this particular […]
